Andrea L. O. Hebb
Department of Pharmacology
Dalhousie University
Halifax
NS B3H 1X5
Canada
Name/email consistency: high
- Human kallikrein 6 cerebrospinal levels are elevated in multiple sclerosis. Hebb, A.L., Bhan, V., Wishart, A.D., Moore, C.S., Robertson, G.S. Curr. Drug. Discov. Technol (2010)
- Cholecystokinin and endogenous opioid peptides: interactive influence on pain, cognition, and emotion. Hebb, A.L., Poulin, J.F., Roach, S.P., Zacharko, R.M., Drolet, G. Prog. Neuropsychopharmacol. Biol. Psychiatry (2005)
- Intracerebroventricular D-Pen2, D-Pen5-enkephalin administration soon after stressor imposition influences behavioral responsivity to a subsequent stressor encounter in CD-1 mice. Hebb, A.L., Drolet, G., Mendella, P.D., Roach, S.P., Gauthier, M.S., Zacharko, R.M. Pharmacol. Biochem. Behav. (2005)
- Central D-Ala2-Met5-enkephalinamide mu/delta-opioid receptor activation reverses the anxiogenic-like properties of cholecystokinin on locomotor and rearing activity in CD-1 mice. Hebb, A.L., Zacharko, R.M. Brain Res. (2003)
- Central D-Ala2-Met5-enkephalinamide mu/delta-opioid receptor activation blocks behavioral sensitization to cholecystokinin in CD-1 mice. Hebb, A.L., Zacharko, R.M. Brain Res. (2003)
- Exposure of mice to a predator odor increases acoustic startle but does not disrupt the rewarding properties of VTA intracranial self-stimulation. Hebb, A.L., Zacharko, R.M., Gauthier, M., Drolet, G. Brain Res. (2003)
- Differential startle reactivity following central CCK-8S and systemic Boc CCK-4 administration in mice: antecedent stressor history and testing condition. Hebb, A.L., Zacharko, R.M., Bowie, J.P., Drolet, G. Behav. Neurosci. (2003)









